Both positions were newly created as the agency has grown over the past year.
Calman is joining the technology company as VP of comms for Watson Health.
A mentor once told him to keep learning and stay out of his comfort zone.
She will also continue to serve as president of the Astellas U.S.A. Foundation.
Former Edelman executive Mary Corcoran replaces Annalise Coady, who becomes president of W2O EMEA.
Celgene and Agios secure FDA approval for AML drug Idhifa; GSK hires chief digital and technology officer; Pfizer wants tax reform before M&A engagement
David Musselman and Lynn Gerber are now leading sales for the company's primary care and specialty products.
Novartis raises Alcon forecast; UDG acquires Cambridge BioMarketing; Spark Therapeutics receives priority review for Luxturna gene therapy
AstraZeneca CEO reportedly moving to Teva; the FDA reverses on approval for Amicus drug; Merck names winners of Alexa challenge
When you've figured out the difference, people will walk through fire for you, a mentor once told her.
The CEOs of the industry's largest holding companies discuss how they're reasserting their businesses.
Walgreens ends merger with Rite Aid; Biogen hires former Novartis exec as SVP of corporate affairs; FDA takes new measures to drive drug pricing competition
Zaritsky succeeds Jay Bolling, who becomes executive chairman
The executive director of oncology marketing is fascinated by the resilience of the human body.
Brian Goff is expected to replace Carsten Thiel in June. The drugmaker said Tuesday that Thiel along with several other execs would be leaving the firm.
Holly Henry, previously chief medical officer at FCB Health, will oversee medical strategy in the newly created role.
Alexion names former Baxalta head as CEO; U.S. dollar drops after AHCA-fail; EMA advises suspension of 300 generic drugs by Indian drugmaker
P&G's Mark Chakravarty has joined pharma giant Novartis in a senior role.
Healthcare is sometimes about life or death, but is almost always about quality of life, says the EVP of health system products and strategy.
Ten drugmakers seek to exclude pricing information from proxy ballots; roughly 85% of patient advocacy groups get industry funding; Juno halts lead CAR-T project
Dennis Urbaniak has also been named chief digital officer at Havas Lynx.
Novo Nordisk appoints new CEO, and more people moves for you to know about
A bout with Lyme disease led Yee to found a company that helps patients measure and track their breathing patterns.
Pharma among top sponsors of Trump inauguration parties; AstraZeneca exec to replace GSK president of global pharmaceuticals; EpiPen rival to relaunch
Deborah Furey will lead the agency's pilot of a new personalized marketing offering.
MM&M last year named its inaugural class of 16 Femmes and 20 Women to Watch. Who should be considered for this year's list of breakthough women?
Endo hires new head of U.S. branded pharma, and three other people moves for you to know about.
DeViteri started in the newly created role this month.
She says her experience in consumer brands helps her push healthcare clients to be more creative.
The merger of Quintiles and IMS Health closed in October.